CLSA reiterated its Outperform rating on Anheuser Busch Inbev SA (ADR) (NYSE: BUD) and retained the 12-month price objective of $145.00.
Analysts, led by Caroline Levy, see an imminent inflection point, indicating the shift in rapidly-growing high-end brands.
Latest Ratings for BUD
|May 2016||Bernstein||Maintains||Market Perform|
|Apr 2016||Societe Generale||Downgrades||Hold||Buy|
Powered by WPeMatico